Results 81 to 90 of about 53,718 (156)

Nebivolol effect on doxorubicin-induced cardiotoxicity in breast cancer

open access: yes, 2018
Flavia Cochera,* Daniel Dinca,* Diana Aurora Bordejevic, Ioana Mihaela Citu, Adelina Marioara Mavrea, Minodora Andor, Mihai Trofenciuc, Mirela Cleopatra Tomescu Cardiology Department, “Victor Babes” University of Medicine and Pharmacy ...
Tomescu MC   +7 more
core  

Effects of the vasodilating beta-blocker nebivolol on smoking-induced endothelial dysfunction in young healthy volunteers

open access: yes, 2008
André C Schmidt1, Burkhard Flick1, Elke Jahn2, Peter Bramlage31Charité – Universitätsmedizin Berlin, Institute for Clinical Pharmacology and Toxikology, Berlin, Germany; 2Berlin-Chemie AG, Clinical Research and Medical ...
Burkhard Flick   +3 more
core  

A review of the safety and efficacy of nebivolol in the mildly hypertensive patient

open access: yes, 2008
John CockcroftWales Heart Research Institute, University Hospital Heath Park, Cardiff, UKAbstract: Nebivolol is a third generation beta-blocker, which can be distinguished from other beta-blockers by its hemodynamic profile.
John Cockcroft
core  

Antiarrhythmic Properties of Beta Blockers: Focus on Nebivolol [PDF]

open access: yes
Beta-blockers are commonly used medications for cardiovascular diseases. Beta-blockers are effective antiarrhythmic agents, and they are class 2 agents in the Vaughan-Williams classification.
Çağlar Özmen   +7 more
core   +1 more source

Nebivolol Hydrochloride-Amino Acid Zwitterionic Cocrystals with Superior Physicochemical Characteristics

open access: yesInternational Journal of Pharmaceutical And Phytopharmacological Research, 2023
Chinna Devi   +4 more
openaire   +1 more source

Blockade of ß-Adrenergic Receptors by Nebivolol Enables Tumor Control Potential for Uveal Melanoma in 3D Tumor Spheroids and 2D Cultures. [PDF]

open access: yesInt J Mol Sci, 2023
Farhoumand LS   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy